ciprofloxacin has been researched along with Diffuse Cutaneous Systemic Sclerosis in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| " To determine if oral ciprofloxacin reduces the severity of scleroderma, a controlled, double-blind randomized clinical trial, with placebo, was conducted on 32 patients with diffuse and limited scleroderma, who received oral ciprofloxacin (250 mg) or placebo every 12 h." | 5.14 | Ciprofloxacin utility as antifibrotic in the skin of patients with scleroderma. ( Agustín, OR; Antonio, FM; Huerta, M; Iván, DE; Manuel, VR; Rubén, EC, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rubén, EC | 1 |
| Manuel, VR | 1 |
| Agustín, OR | 1 |
| Huerta, M | 1 |
| Antonio, FM | 1 |
| Iván, DE | 1 |
1 trial available for ciprofloxacin and Diffuse Cutaneous Systemic Sclerosis
| Article | Year |
|---|---|
Ciprofloxacin utility as antifibrotic in the skin of patients with scleroderma.
Topics: Administration, Oral; Adult; Ciprofloxacin; Female; Fibrosis; Humans; Kidney; Liver; Male; Middle Ag | 2010 |